January 22, 2016.
Nephron Pharmaceuticals is to cut 250 jobs at its Orlando, FL manufacturing facility, according to the Orlando Business Journal.â¨â¨ In October 2015, Nephron filed a WARN notice stating that 400 employees - almost its entire Orlando workforce - would be laid off between Jan. 1-15. But CEO Lou Kennedy later confirmed that only 180 of the 450 employees received layoff notices. Nephron is shifting operations to South Carolina on account of the state's attractive tax incentives.
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.